Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gustaaf de Ridder

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Methods in Enzymology|January 27, 2011
Modulation of the unfolded protein response by GRP78 in prostate cancerGustaaf de Ridder, Rupa Ray, Uma K Misra, et al.
Gene|May 22, 2003
Plac8 and Plac9, novel placental-enriched genes identified through microarray analysisCarlos Galaviz-Hernandez, Carole Stagg, Gustaaf de Ridder, et al.
Journal of Thrombosis and Haemostasis : JTH|August 25, 2021
Novel venous thromboembolism mouse model to evaluate the role of complete and partial factor XIII deficiency in pulmonary embolism riskSravya Kattula, Yaqiu Sang, Gustaaf de Ridder, et al.
International Journal of Clinical and Experimental Medicine|August 11, 2017
Upregulation of autophagy genes and the unfolded protein response in human heart failureBrian C Jensen, Scott J Bultman, Darcy Holley, et al.
Journal of Clinical Apheresis|March 7, 2026
Guidance for Documentation of Therapeutic Apheresis Interventions in the Medical Record: An American Society for Apheresis (ASFA) Practice PerspectiveChester Andrzejewski, Yanhua Li, Ding Wen Wu, et al.
Breast Cancer Research : BCR|July 5, 2015
Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistanceShenduo Li, Sturgis Payne, Fang Wang, et al.
Oncotarget|October 22, 2016
Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surfaceErik R Nelson, Shenduo Li, Margaret Kennedy, et al.
Blood|July 7, 2022
Race, rituximab, and relapse in TTPShruti Chaturvedi, Ana G Antun, Andrew M Farland, et al.
Blood Advances|December 3, 2024
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab eraAyotola Fatola, Michael D Evans, Jenna Brown, et al.
Research and Practice in Thrombosis and Haemostasis|April 23, 2024
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpuraMouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Methods in Enzymology|January 27, 2011
Modulation of the unfolded protein response by GRP78 in prostate cancerGustaaf de Ridder, Rupa Ray, Uma K Misra, et al.
Gene|May 22, 2003
Plac8 and Plac9, novel placental-enriched genes identified through microarray analysisCarlos Galaviz-Hernandez, Carole Stagg, Gustaaf de Ridder, et al.
Journal of Thrombosis and Haemostasis : JTH|August 25, 2021
Novel venous thromboembolism mouse model to evaluate the role of complete and partial factor XIII deficiency in pulmonary embolism riskSravya Kattula, Yaqiu Sang, Gustaaf de Ridder, et al.
International Journal of Clinical and Experimental Medicine|August 11, 2017
Upregulation of autophagy genes and the unfolded protein response in human heart failureBrian C Jensen, Scott J Bultman, Darcy Holley, et al.
Journal of Clinical Apheresis|March 7, 2026
Guidance for Documentation of Therapeutic Apheresis Interventions in the Medical Record: An American Society for Apheresis (ASFA) Practice PerspectiveChester Andrzejewski, Yanhua Li, Ding Wen Wu, et al.
Breast Cancer Research : BCR|July 5, 2015
Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistanceShenduo Li, Sturgis Payne, Fang Wang, et al.
Oncotarget|October 22, 2016
Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surfaceErik R Nelson, Shenduo Li, Margaret Kennedy, et al.
Blood|July 7, 2022
Race, rituximab, and relapse in TTPShruti Chaturvedi, Ana G Antun, Andrew M Farland, et al.
Blood Advances|December 3, 2024
Relapse-free survival is progressively shortened in a subset of Black patients with immune-mediated TTP treated in the rituximab eraAyotola Fatola, Michael D Evans, Jenna Brown, et al.
Research and Practice in Thrombosis and Haemostasis|April 23, 2024
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpuraMouhamed Yazan Abou-Ismail, Chong Zhang, Angela P Presson, et al.
Pageof 1